Stem cells as vectors for antitumour therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 20388765.
- Also identified by DOI 10.1136/thx.2009.128025 and PMC identifier 3401681.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent research suggests that mesenchymal stem cells (MSCs) are able to migrate specifically to tumours and their metastases throughout the body. This has led to considerable excitement about the possibility of modifying these cells to express anticancer molecules and using them as specific targeted anticancer agents. However, there are concerns that systemically delivered MSCs may have non-desirable effects, and there are also many unanswered questions including the mechanism of tumour homing. This review investigates the different MSC-delivered anticancer agents, addresses the questions and concerns, and tries to place this potential therapy in future cancer management.
Medical subject headings
- Genetic Therapy
- Genetic Vectors
- Mesenchymal Stem Cell Transplantation
- Neoplasms